Home › Funds › 72 Investment Holdings, LLC › ANRO
72 Investment Holdings, LLC position in ANRO
ALTO NEUROSCIENCE INC COM SHS · Health Care
72 Investment Holdings, LLC reported holding 667,778 shares of ANRO (ALTO NEUROSCIENCE INC COM SHS) in its Q2 2026 13F filing — a position valued at US$17.6M, representing 35.27% of its reported portfolio and ranking #2 among its reported holdings. 72 Investment Holdings, LLC has disclosed ANRO holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 72 Investment Holdings, LLC's ANRO position evolved
72 Investment Holdings, LLC first disclosed a stake in ANRO in Q1 2024 at 667,778 shares (US$10.3M). The position peaked in Q2 2026 at 667,778 shares, worth US$17.6M. Across 10 filings, 72 Investment Holdings, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 667,778 shares valued at US$17.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 667.78K | $10.25M | New |
| Q2 2024 | 667.78K | $7.14M | Hold |
| Q3 2024 | 667.78K | $7.64M | Hold |
| Q4 2024 | 667.78K | $2.82M | Hold |
| Q1 2025 | 667.78K | $1.44M | Hold |
| Q2 2025 | 667.78K | $1.47M | Hold |
| Q3 2025 | 667.78K | $2.68M | Hold |
| Q4 2025 | 667.78K | $11.89M | Hold |
| Q1 2026 | 667.78K | $15.01M | Hold |
| Q2 2026 | 667.78K | $17.62M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANRO and 13F data
ANRO (ALTO NEUROSCIENCE INC COM SHS) is a Health Care company. 58 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$97.8M), Commodore Capital LP (US$71.9M), PERCEPTIVE ADVISORS LLC (US$42.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANRO
- Alpha Wave Global, LP 3.71M sh · $97.85M · Q2 2026
- Commodore Capital LP 2.72M sh · $71.87M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.61M sh · $42.49M · Q2 2026
- Spruce Street Capital LP 1.35M sh · $35.71M · Q2 2026
- Vivo Capital, LLC 1.21M sh · $31.90M · Q2 2026
- ARMISTICE CAPITAL, LLC 864.00K sh · $22.80M · Q2 2026
- Affinity Asset Advisors, LLC 850.00K sh · $22.43M · Q2 2026
- Vestal Point Capital, LP 785.00K sh · $20.72M · Q2 2026
- Venrock Adviser, LLC 500.00K sh · $13.20M · Q2 2026
- Parkman Healthcare Partners LLC 429.04K sh · $11.32M · Q2 2026
- Ikarian Capital, LLC 407.34K sh · $10.75M · Q2 2026
- Saturn V Capital Management LP 182.83K sh · $4.82M · Q2 2026
More on 72 Investment Holdings, LLC
FAQ
How long has 72 Investment Holdings, LLC held ANRO?
72 Investment Holdings, LLC has disclosed ANRO holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is 72 Investment Holdings, LLC's current position in ANRO?
As of Q2 2026, 72 Investment Holdings, LLC holds 667.78K shares of ANRO (ALTO NEUROSCIENCE INC COM SHS), valued at $17.62M, representing 35.27% of its reported portfolio and ranking #2.
Has 72 Investment Holdings, LLC been buying or selling ANRO?
In the latest 13F filing (Q2 2026), 72 Investment Holdings, LLC held unchanged its position in ANRO. The position peaked in Q2 2026 at 667.78K shares.
Which other funds hold ANRO?
Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.